#USA #Fort Myers #Cancer Care #Florida Cancer #Ambient AI

Revolutionizing Cancer Care with Ambient AI

The Florida Cancer Specialists & Research Institute (FCS) is at the forefront of integrating advanced technology into cancer care, as demonstrated in a recent study coauthored by its President and Managing Physician, Dr. Lucio N. Gordan. This pivotal research highlights the tangible benefits of ambient artificial intelligence (AI) in enhancing cancer care efficiency while reducing the administrative burden on healthcare providers. In particular, the study explores how this technology promotes smoother documentation processes, allowing providers to focus more on patient care rather than paperwork.

Study Overview

Presented at the JADPRO 2026 conference, the study stands out as one of the first to offer concrete evidence of testing and improving documentation efficiency in community oncology practices. By using ambient AI scribe technology across three institutions, the research analyzed pre- and post-implementation data from 85 advanced practice providers (APPs). The results indicated encouraging changes in documentation practices, compliance rates, workflow efficiency, and provider burnout.

Key Findings

1. Documentation Efficiency: The implementation of ambient AI dramatically reduced incomplete notes by an impressive 73% to 81%. Furthermore, the time spent on documentation decreased by 53% to 66%, indicating a swift transition towards more effective record-keeping.

2. Timely Chart Completion: As a result of the ambient AI integration, practices experienced a significant boost in documentation compliance. There was a notable 67% reduction in pending notes within the 3-5 day range and a complete elimination of notes hanging for 6-9 days. Such improvements promise timely patient care management and streamlined follow-up procedures.

3. Provider Experience: Feedback from APPs confirmed a highly positive reception of the ambient AI technology. Crucially, 81% of respondents reported improved well-being and reductions in burnout risk. Nearly all indicated confidence in the quality of their documentation and expressed intentions to continue using the technology. A remarkable 97% felt the technology positively affected their patient interactions, emphasizing the shift from administrative tasks to engaging directly with patients.

Dr. Gordan remarks, _"As cancer care grows increasingly complex, leveraging innovative tools is crucial for both patient and provider support. The progress observed in documentation efficiency, compliance, and provider experience underscores the impact ambient AI can have in community oncology practices."_

Future Directions

The usage of ambient AI technology is accelerating quickly across the healthcare sector. FCS continues to prioritize the careful evaluation and integration of innovations that can enhance the experience of care for both providers and patients. Addressing intricacies in cancer care with sophisticated technologies like ambient AI represents a significant step forward towards improved clinical outcomes.

This transformative approach aligns with FCS's mission to provide world-class care and advanced treatment options through clinical trials and research partnerships. As a leader in oncology, FCS collaborates with organizations such as the Sarah Cannon Research Institute, facilitating access to groundbreaking therapies for patients right at home.

As technological innovations continue to reshape healthcare landscapes, the findings from this study will likely influence how oncology practices address documentation challenges and provider burnout moving forward. With over 180 active clinical trials annually, FCS remains committed to being a beacon of innovative cancer care—a commitment enriched by the adoption of ambient AI technology.